Hypothalamic Oxytocin Neuron Activation Attenuates Intermittent Hypoxia-Induced Hypertension and Cardiac Dysfunction in an Animal Model of Sleep Apnea

• Published in: Hypertension (Dallas, Tex. 1979) Tex. 1979), 2023-04, Vol.80 (4), p.882-894
• Main Authors: Rodriguez, Jeannette, Escobar, Joan B., Cheung, Emily C., Kowalik, Grant, Russo, Rebekah, Dyavanapalli, Jhansi, Alber, Bridget R., Harral, Grey, Gill, Aman, Melkie, Makeda, Jain, Vivek, Schunke, Kathryn J., Mendelowitz, David, Kay, Matthew W.
• Format: Article
• Language: English
• Subjects: Animals; Cardiovascular Diseases - complications; Disease Models, Animal; Heart Diseases; Hypertension; Hypoxia - metabolism; Neurons - metabolism; Oxytocin - pharmacology; Rats; Rats, Sprague-Dawley; Sleep Apnea, Obstructive - complications
• ISSN: 0194-911X; 1524-4563
• DOI: 10.1161/HYPERTENSIONAHA.122.20149

Obstructive sleep apnea is a prevalent and poorly treated cardiovascular disease that leads to hypertension and autonomic imbalance. Recent studies that restore cardiac parasympathetic tone using selective activation of hypothalamic oxytocin neurons have shown beneficial cardiovascular outcomes in animal models of cardiovascular disease. This study aimed to determine if chemogenetic activation of hypothalamic oxytocin neurons in animals with existing obstructive sleep apnea-induced hypertension would reverse or blunt the progression of autonomic and cardiovascular dysfunction. Two groups of rats were exposed to chronic intermittent hypoxia (CIH), a model of obstructive sleep apnea, for 4 weeks to induce hypertension. During an additional 4 weeks of exposure to CIH, 1 group was treated with selective activation of hypothalamic oxytocin neurons while the other group was untreated. Hypertensive animals exposed to CIH and treated with daily hypothalamic oxytocin neuron activation had lower blood pressure, faster heart rate recovery times after exercise, and improved indices of cardiac function compared with untreated hypertensive animals. Microarray analysis suggested that, compared with treated animals, untreated animals had gene expression profiles associated with cellular stress response activation, hypoxia-inducible factor stabilization, and myocardial extracellular matrix remodeling and fibrosis. In animals already presenting with CIH-induced hypertension, chronic activation of hypothalamic oxytocin neurons blunted the progression of hypertension and conferred cardioprotection after an additional 4 weeks of CIH exposure. These results have significant clinical translation for the treatment of cardiovascular disease in patients with obstructive sleep apnea.